Exploring the Effects of Aerobic Exercise Combined With BFRT on Patients With COPD
Exploring the Effects of Aerobic Exercise Combined With Blood Flow Restriction Training on Exercise Capacity, Cardiopulmonary Functions, and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease
Investigate the effects of exercise training on the cardiopulmonary function and exercise capacity in COPD patients.
調査の概要
状態
条件
詳細な説明
The systemic effects of Chronic Obstructive Pulmonary Disease (COPD) can precipitate a series of complications, including cardiovascular disorders, muscle atrophy, and osteoporosis. These comorbid conditions often result in decreased physical activity and suboptimal physical fitness, compelling patients to lead a sedentary lifestyle to mitigate exercise-induced dyspnea. Addressing the limitations in exercise tolerance remains a critical therapeutic goal in the treatment of COPD. According to research, exercise intolerance is caused by both poor pulmonary function and associated skeletal muscle dysfunction. Blood flow restriction training, a new rehabilitation technique, has shown promise in improving muscular strength at lower exercise intensities and in shorter timeframes, presenting a fresh approach to COPD rehabilitation.
The research aims to investigate the impact of incorporating blood flow restriction training into a holistic aerobic exercise program on exercise capacity and quality of life among patients with COPD. The findings are intended to clarify the potential of this innovative training technique as a supplementary therapeutic strategy in the management of COPD.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Kun-Ling Tsai, Ph.D.
- 電話番号:5078 886-6-2353535
- メール:kunlingtsai@mail.ncku.edu.tw
研究連絡先のバックアップ
- 名前:Yu-Ting Huang, M.S.
- 電話番号:5078 886-6-2353535
- メール:t66061053@pt.ncku.edu.tw
研究場所
-
-
Taiwan
-
Tainan、Taiwan、台湾、701
- 募集
- National Cheng Kung University Hostipal
-
コンタクト:
- Kun-Ling Tsai, PhD
- 電話番号:6219 062353535
- メール:kunlingtsai@mail.ncku.edu.tw
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- COPD classified as levels 2-4.
- Stable condition without worsening in the past three months.
- No participation in any rehabilitation program within the past six months.
- Ability to understand and follow verbal commands and cooperate with an exercise training program.
Exclusion Criteria:
- Unconscious or unable to cooperate with the evaluator.
- Hospitalization due to acute illness within the past three months.
- Severe joint diseases or history of lower limb surgery.
- Severe cardiovascular disease (e.g., presence of a cardiac pacemaker or acute myocardial infarction within the past six months).
- Dependence on oxygen supply.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:Usual care group
The Usual care group will receive COPD and exercise-related education. |
The participants will be provided by educational program about COPD self-care and home-based exercise approach. |
|
実験的:Aerobic exercise group-cycling
The aerobic exercise group will receive cycling training intervention 2-3 times per week for 2 months. |
The aerobic exercise intervention will utilize an ergometer. The program will be conducted 2-3 times per week over a 3-month period. |
|
実験的:BFR group-cycling + BFR
The BFR group will receive cycling training combined with BFR intervention 2-3 times per week for 2 months. |
Blood flow restriction (BFR) intervention will combine aerobic exercise on the ergometer with BFR training. The program will be conducted 2-3 times per week over a 3-month period. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Oxygen consumption (VO2)
時間枠:Change from baseline (0 week) to follow up (20 weeks)
|
Oxygen consumption examined by cardiopulmonary exercise test |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Functional capacity
時間枠:Change from baseline (0 week) to follow up (20 weeks)
|
Functional capacity examined by 6MWT |
Change from baseline (0 week) to follow up (20 weeks)
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Heart Rate Variability
時間枠:Change from baseline (0 week) to follow up (20 weeks)
|
Heart Rate Variability examined by autonomic nervous system |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Pulmonary function test
時間枠:Change from baseline (0 week) to follow up (20 weeks)
|
Pulmonary function test examined by spirometer. Spirometry is a physiological test that measures the ability to inhale and exhale air over time. The main spirometry results are forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), and the FEV1/FVC ratio. |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Maximum respiratory pressure
時間枠:Change from baseline (0 week) to follow up (20 weeks)
|
Maximum respiratory pressure examined by pressure meter |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Quality of life score (COPD-related questionnaire-I)
時間枠:Change from baseline (0 week) to follow up (20 weeks)
|
Quality of life score examined by mMRC Questionnaire. |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Quality of life score (COPD-related questionnaire-II)
時間枠:Change from baseline (0 week) to follow up (20 weeks)
|
COPD Assessment Test (CAT) questionaire |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Quality of life score (COPD-related questionnaire-III)
時間枠:Change from baseline (0 week) to follow up (20 weeks)
|
St George's Respiratory Questionnaire (SGRQ) |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Diaphragm capacity
時間枠:Change from baseline (0 week) to follow up (20 weeks)
|
Diaphragm capacity examined by diaphragmatic ultrasound |
Change from baseline (0 week) to follow up (20 weeks)
|
協力者と研究者
捜査官
- 主任研究者:Kun-Ling Tsai, Ph.D.、Department of Physical Therapy, National Cheng Kung University
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
- B-ER-113-298
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
IPD sharing plan will be decided after summarized data being published.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。